메뉴 건너뛰기




Volumn 16, Issue 6, 2008, Pages 2974-2983

Erratum to "Achiral, selective CCK2 receptor antagonists based on a 1,3,5-benzotriazepine-2,4-dione template" [Bioorg. Med. Chem. 16 (2008) 2974-2983] (DOI:10.1016/j.bmc.2007.12.047);Achiral, selective CCK2 receptor antagonists based on a 1,3,5-benzotriazepine-2,4-dione template

Author keywords

Antagonist; Benzotriazepine; CCK; CCK2; Gastrin

Indexed keywords

1H 1,3,5 BENZOTRIAZEPINE 2,4 (3H,5H)DIONE; 2 [1 CYCLOHEPTYL 2,4 DIOXO 5 (2 OXO 2 PYRROLIDIN 1 YL ETHYL) 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]N 3 TOLYL ACETAMIDE; 2 [1 CYCLOHEPTYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]N 3 TOLYL ACETAMIDE; 2 [1 CYCLOHEPTYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]N [3 (5 OXO 2,5 DIHYDRO[1,2,4]OXADIAZOL 3 YL)PHENYL]ACETAMIDE; 2 [1 CYCLOHEXYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]N (3 METHYLAMINO PHENYL)ACETAMIDE; 2 [1 CYCLOHEXYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]N [3 (2 METHYL THIAZOL 4 YL)PHENYL]ACETAMIDE; 2 [1 CYCLOHEXYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]N [3 (5 OXO 2,5 DIHYDRO[1,2,4]OXADIAZOL 3 YL)PHENYL]ACETAMIDE; 2 [1 CYCLOHEXYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]N [3 [METHYL(2H TETRAZOL 5 YL)AMINO]PHENYL]ACETAMIDE; 2 [2,4 DIOXO 1 (2 OXO 2 PYRROLIDIN 1 YL ETHYL) 5 PHENYL 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]N PHENYL ACETAMIDE; 3 [2 (2,4 DIOXO 1 (2 OXO 2 PYRROLIDIN 1 YL ETHYL) 5 PHENYL 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL)ACETYLAMINO]BENZOIC ACID; 3 [3[ 2 [1 CYCLOHEXYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]ACETYLAMINO]PHENYL]PROPIONIC ACID; 4 [1 CYCLOHEXYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]N [3 (5 OXO 2,5 DIHYDRO[1,2,4]OXADIAZOL 3 YL)PHENYL]BUTYRAMIDE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; [3[ 2 [1 CYCLOHEPTYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]ACETYLAMINO]PHENYLSULFANYL]ACETIC ACID; [3[ 2 [1 CYCLOHEPTYL 5 (3,3 DIMETHYL 2 OXO BUTYL) 2,4 DIOXO 1,2,4,5 TETRAHYDRO 1,3,5 BENZOTRIAZEPIN 3 YL]ACETYLAMINO]PHENYL]ACETIC ACID; BENZAZEPINE DERIVATIVE; CHOLECYSTOKININ B RECEPTOR; TRIAZINE DERIVATIVE;

EID: 40949147712     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.05.070     Document Type: Erratum
Times cited : (22)

References (36)
  • 24
    • 40949144607 scopus 로고    scopus 로고
    • Bayer, A. G. German Patent Application. DE2036172, 1972.
    • Bayer, A. G. German Patent Application. DE2036172, 1972.
  • 26
    • 40949122139 scopus 로고    scopus 로고
    • James Black Foundation Ltd, UK. PCT International Patent Application. WO 2003041714, 2003.
    • James Black Foundation Ltd, UK. PCT International Patent Application. WO 2003041714, 2003.
  • 34
    • 40949125845 scopus 로고    scopus 로고
    • Merck Sharp and Dohme Ltd. PCT International Patent Application. WO 9319063, 1993.
    • Merck Sharp and Dohme Ltd. PCT International Patent Application. WO 9319063, 1993.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.